The company is involved in the manufacturing and global marketing of a diverse range of pharmaceuticals both in India and internationally. Dr. Reddy’s Labs recently acquired MenoLabs from Amyris ...

Orchid Pharma's newly-formed antimicrobial solutions division is targeting a turnover of up to Rs 300 crore in the next three ...

Shares of Mankind Pharma rose 7% after Investec initiated coverage with a 'buy' rating. The company, known for its 36 brands, ...

The Nifty Pharma has gained around 37% year to date. The growth continues to be led by the US sales and well supported by ...

We have also seen Multinational companies (MNCs ... he was actively tracking US Pharma sector. He holds a medicine and management degree from premier institute in India. He has practiced as ...

Lupin has announced a non-exclusive patent licence agreement with Takeda for the commercialisation of Vonoprazan Tablets in ...

The Indian biotechnology sector is a rapidly advancing segment within the economy, often referred to as a sunrise sector due ...

Elara Capital said that organic growth will be in the range of 11-14 per cent for pharma stocks but will fall short of our ...

Lupin Limited partners with Takeda to launch Vonoprazan tablets in India, targeting acid peptic disorders with Lupivon brand.

PresVu has been suspended by the DCGI due to misleading marketing claims that the eye drops can "cure" near-sightedness.

DCGI suspends Entod Pharma`s eye drop permission for presbyopia treatment due to unapproved claims. The company will ...

Chicago Rockford International (RFD) is targetting further growth in the pharma trade from India after recently welcoming its ...